Health Condition 1: L649- Androgenic alopecia, unspecified
Conditions
Interventions
Intervention1: COMBINATION OF 5% MINOXIDIL PLUS 0.10% FINASTERIDE WITH ORAL PLACEBO: COMBINATION OF 5% MINOXIDIL PLUS 0.10% FINASTERIDE 1ML LA BD ALONG WITH ORAL PLACEBO (ELEMENTAL CALCIUM 500MG WITH
Sponsors
RESEARCH CELL ALL INDIA INSTITUTE OF MEDICAL SCIENCES JODHPUR
Eligibility
Inclusion criteria
Inclusion criteria: Patients who give informed written consent and fulfilling all the following criteria will be included in the study 1.Age more than or equal to 18 years and less than or equal to 50 years 2.Clinical diagnosis of androgenic alopecia. 3.Grade I, II , III , III vertex and IV of Hamilton Norwood grading.
Exclusion criteria
Exclusion criteria: Patient having any of the following criteria will be excluded from the study. 1.Known sensitivity to either topical minoxidil or topical finasteride or oral biotin. 2.Known hypotensive 3.Inability to take oral medications. 4.Uncontrolled gastrointestinal infection/malabsorption syndrome 5.Had used topical minoxidil/topical finasteride/oral supplement/oral herbal extract/any OTC medication for hair growth within the past 1 month 6.Patients with diffuse hair loss (telogen effluvium) 7.Patient with scarring alopecias 8.Patient with severe/uncontrolled scalp diseases-seborrheic dermatitis, scalp infection, scalp psoriasis.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.To compare the efficacy of hair regrowth in the 3 groups using global photography and dermoscopy. Timepoint: 4,8,12,16,20, 24 WEEKS | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.To compare the efficacy of hair regrowth in the 3 groups using the subjective VAS scale. 2.To compare the side effects experienced in each group Timepoint: VAS AT 12,24 WEEKS. SIDE EFFECTS AT 4,8,12,16,20,24 WEEKS | — |
Countries
India
Contacts
Public ContactDR YAMINI SIHAG
AIIMS JODHPUR
Outcome results
None listed